Use of Aromatherapy in Conjunction With Physical/Occupational Therapy in an Acute Care Setting
Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO · Mar 7, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The study intervention consists of 3 essential oils: lavender, mandarin and peppermint administered on an inhalation patch affixed in the chest region of the participant gown. The inhalation patch consists of hydrogel cast onto polyester film, supported by non-woven polyester fabric, covered with a polyethylene film. The proprietary foil-backed lamination on the patch is used to provide an occlusive barrier that prevents any essential oil from being absorbed through the skin. The placebo will consist of a comparable sized felt patch with adhesive backing with no essential oil applied.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Inpatients of acute care setting at University Health hospital
- • 2. Provision of a signed and dated informed consent form
- • 3. English or Spanish speaking
- • 4. Male or Female, aged 18 years and older
- • 5. Willing to comply with all study procedures
- Exclusion Criteria:
- • 1. Respiratory disorders, e.g., asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, lung cancer, cystic fibrosis, pneumonia, pleural effusion
- • 2. Cognitive impairment
- • 3. Unable to communicate
- • 4. Admitted to the closed access unit or to psychiatry
- • 5. Allergic to lavender, mandarin or peppermint oil
- • 6. Diseases that cause olfactory disorders such as: COVID-19, benign growths or polyps, congestion from a cold, sinus infection or allergy flare-up
- • 7. Drugs that may cause loss of the ability to smell e.g., intranasal zinc products, decongestant nose sprays and certain oral drugs such as nifedipine and phenothiazines
- • 8. Pregnant women (self-reported)
- • 9. Prisoner
About The University Of Texas Health Science Center At San Antonio
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is a leading academic medical institution dedicated to advancing health through education, research, and patient care. As a prominent sponsor of clinical trials, UT Health San Antonio focuses on innovative medical research aimed at improving health outcomes across diverse populations. With a commitment to excellence, the institution fosters collaboration among its multidisciplinary teams to explore cutting-edge therapies and interventions. Through rigorous scientific inquiry and ethical practices, UT Health San Antonio strives to make meaningful contributions to the field of medicine and enhance the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Antonio, Texas, United States
San Antonio, Texas, United States
Patients applied
Trial Officials
Bianca Gonzales, OTR, CNT, EdD, MOT
Principal Investigator
University Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials